Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
Di Giacomo, Anna Maria, MD, Ascierto, Paolo A, MD, Pilla, Lorenzo, MD, Santinami, Mario, MD, Ferrucci, Pier Francesco, MD, Giannarelli, Diana, PhD, Marasco, Antonella, MD, Rivoltini, Licia, MD, Simeone, Ester, PhD, Nicoletti, Stefania VL, MD, Fonsatti, Ester, PhD, Annesi, Diego, PhD, Queirolo, Paola, MD, Testori, Alessandro, MD, Ridolfi, Ruggero, MD, Parmiani, Giorgio, MD, Maio, Michele, Dr
Published in The lancet oncology (01.09.2012)
Published in The lancet oncology (01.09.2012)
Get full text
Journal Article